Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 4,699 shares at $1.60 ($8K) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Scheduled sale ($8k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |
| ACOR | SELL | 2016-12-16 | $834K | — | Filing → |